智飞生物
(300122)
| 流通市值：340.71亿 | | | 总市值：576.66亿 |
| 流通股本：14.14亿 | | | 总股本：23.94亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 22,786,306,742.43 | 18,258,441,511.25 | 11,395,682,504.71 | 52,917,767,029.2 |
| 营业收入 | 22,786,306,742.43 | 18,258,441,511.25 | 11,395,682,504.71 | 52,917,767,029.2 |
| 二、营业总成本 | 19,685,884,775.99 | 15,281,723,020.21 | 9,323,352,619.26 | 43,094,356,363.43 |
| 营业成本 | 16,581,424,751.22 | 13,392,373,224.53 | 8,427,082,289.55 | 38,674,261,773.48 |
| 税金及附加 | 111,443,937.96 | 88,915,782.14 | 50,142,915.61 | 238,749,483.8 |
| 销售费用 | 1,936,199,475.15 | 1,115,557,033.68 | 495,132,349.15 | 2,772,628,484.47 |
| 管理费用 | 306,957,937.57 | 202,933,624.52 | 110,948,123.03 | 393,026,825.85 |
| 研发费用 | 695,547,263.17 | 461,348,505.91 | 234,083,332.08 | 968,471,553.03 |
| 财务费用 | 54,311,410.92 | 20,594,849.43 | 5,963,609.84 | 47,218,242.8 |
| 其中:利息费用 | 83,711,440.88 | 49,226,078.22 | 24,481,823.05 | 80,996,119.13 |
| 其中:利息收入 | 57,759,269.89 | 47,180,450.29 | 29,661,965.24 | 67,944,133.72 |
| 资产处置收益 | 54,241.33 | 95,411.72 | - | 41,368,880.15 |
| 资产减值损失(新) | -26,397,568.74 | -12,005,862.6 | -1,028,496.41 | -311,994,206.01 |
| 信用减值损失(新) | -605,073,964.32 | -396,670,992.19 | -340,794,403.21 | -352,708,250.09 |
| 其他收益 | 15,706,250.03 | 10,985,925.73 | 6,155,388.63 | 173,362,445.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 2,484,710,924.74 | 2,579,122,973.7 | 1,736,662,374.46 | 9,373,439,535.35 |
| 加:营业外收入 | 38,091.88 | 38,090.48 | 18,524.81 | 337,687.94 |
| 减:营业外支出 | 6,794,354.14 | 6,456,906.56 | 2,915,829.92 | 31,483,935.61 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,477,954,662.48 | 2,572,704,157.62 | 1,733,765,069.35 | 9,342,293,287.68 |
| 减:所得税费用 | 327,331,724.54 | 338,384,793.01 | 276,020,821.18 | 1,272,425,083.53 |
| 六、净利润 | 2,150,622,937.94 | 2,234,319,364.61 | 1,457,744,248.17 | 8,069,868,204.15 |
| 持续经营净利润 | 2,150,622,937.94 | 2,234,319,364.61 | 1,457,744,248.17 | 8,069,868,204.15 |
| 归属于母公司股东的净利润 | 2,150,622,937.94 | 2,234,319,364.61 | 1,457,744,248.17 | 8,069,868,204.15 |
| (一)基本每股收益 | 0.9 | 0.93 | 0.61 | 3.36 |
| (二)稀释每股收益 | 0.9 | 0.93 | 0.61 | 3.36 |
| 九、综合收益总额 | 2,150,622,937.94 | 2,234,319,364.61 | 1,457,744,248.17 | 8,069,868,204.15 |
| 归属于母公司股东的综合收益总额 | 2,150,622,937.94 | 2,234,319,364.61 | 1,457,744,248.17 | 8,069,868,204.15 |
| 公告日期 | 2024-10-26 | 2024-08-30 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |